Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenoviral entry receptors are a diverse group of cell surface proteins that facilitate the attachment and internalization of adenoviruses into host cells. The specific receptor utilized depends on the adenovirus serotype; for instance, the Coxsackievirus and adenovirus receptor (CAR) is the primary receptor for species C adenoviruses like Ad5, while CD46 (membrane cofactor protein) and Desmoglein-2 (DSG2) are used by various species B serotypes (Bergelson et al., 1997; Gaggar et al., 2003). Following initial binding to these primary receptors, the virus typically interacts with secondary co-receptors, such as alpha-V integrins, to trigger internalization via clathrin-mediated endocytosis (Wickham et al., 1993). These receptors are pivotal in the field of gene therapy and oncolytic virotherapy, as their expression levels on target cells determine the efficiency of viral delivery (Wang et al., 2011). However, the broad expression of these receptors on non-target tissues, such as the liver, can lead to significant off-target effects and sequestration of the viral vector, posing a significant challenge for systemic administration (Koizumi et al., 2003).
Viral vector attachment and internalization via receptor-mediated endocytosis
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenoviral entry receptor.